Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 67.95
-1.95 (-2.79%)
At close: Mar 19, 2026
Ambu A/S Revenue
Ambu A/S had revenue of 1.56B DKK in the quarter ending December 31, 2025, with 3.18% growth. This brings the company's revenue in the last twelve months to 6.09B, up 7.76% year-over-year. In the fiscal year ending September 30, 2025, Ambu A/S had annual revenue of 6.04B with 11.98% growth.
Revenue (ttm)
6.09B
Revenue Growth
+7.76%
P/S Ratio
2.96
Revenue / Employee
1.17M
Employees
5,200
Market Cap
18.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 6.04B | 646.00M | 11.98% |
| Sep 30, 2024 | 5.39B | 616.00M | 12.90% |
| Sep 30, 2023 | 4.78B | 331.00M | 7.45% |
| Sep 30, 2022 | 4.44B | 431.00M | 10.74% |
| Sep 30, 2021 | 4.01B | 446.00M | 12.50% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| H. Lundbeck | 24.63B |
| Genmab | 23.66B |
| Demant | 22.97B |
| GN Store Nord | 16.78B |
| Zealand Pharma | 9.21B |
| ALK-Abelló | 6.31B |
Ambu A/S News
- 2 years ago - ANNUAL REPORT 2022/23 (EARNINGS RELEASE) - GlobeNewsWire
- 3 years ago - Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities - GlobeNewsWire